Skip to main content
. Author manuscript; available in PMC: 2014 Jan 29.
Published in final edited form as: Pediatr Res. 2011 Apr;69(4):293–298. doi: 10.1203/PDR.0b013e31820b937d

Table 2.

Mobility level and epilepsy diagnosis by mutation group

Mutation Mobility level n(%) Epilepsy n(%)
Walks unaided Walks with assistance Doesn’t walk/wheelchair bound Yes No
Carboxyl-terminal truncation 4(33) 3(25) 5(42) 9(75) 3(25)
Large deletion 0(0) 1(14) 6(86) 6(86) 1(14)
No mutation 3(15) 4(20) 13(65) 18(90) 2(10)
Other 1(12) 4(50) 3(38) 7(78) 2(22)
p.R106W 0(0) 0(0) 3(100) 2(67) 1(33)
p.R133C 2(50) 1(25) 1(25) 5(83) 1(17)
p.R168X 1(11) 3(33) 5(56) 7(70) 3(30)
p.R255X 0(0) 1(20) 4(80) 3(60) 2(40)
p.R270X 0(0) 1(33) 2(67) 3(100) 0(0)
p.R294X 4(67) 2(33) 0(0) 5(71) 2(29)
p.R306C 3(50) 2(33) 1(17) 2(33) 4(67)
p.T158M 0(0) 2(40) 3(60) 4(57) 3(43)
TOTAL 18(20) 24(27) 46(53) 71(75) 24(25)